Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple Dose Study of the Safety, Tolerability, and Pharmacokinetics of Lecozotan SR Administered Orally to Healthy Young and Elderly Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Jan 2010
Price :
$35
*
At a glance
- Drugs Lecozotan (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Wyeth
- 03 Nov 2006 New trial record.